| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Microbiology, University of Tennessee, Knoxville, TN 37996
This study evaluates whether the vaginal mucosal surface of immunized mice can prevent invasion by herpes simplex virus (HSV) and aims to identify immune components that affect immunity after challenge at the vaginal mucosa. Despite the induction of both IgA and IgG vaginal Ab following immunization with recombinant vaccinia virus vectors expressing either glycoproteins B or D, viral infection occurred in most animals even after minimal viral dose challenge. Challenged immune animals, including those genetically unable to generate anti-HSV Ab, survived and showed few if any clinical signs of infection. Experiments with T cell subtype knockout animals and depletion with T cell subset-specific MAb indicated that immunity following vaginal challenge was principally dependent on the function of CD4+ T cells. Our results indicate that anti-HSV vaccines may not provide barrier immunity at the vaginal mucosal site but may be adequate to minimize clinical expression of disease.
This article has been cited by other articles:
|
|
 |
|
  A. J. Johnson, C.-F. Chu, and G. N. Milligan Effector CD4+ T-Cell Involvement in Clearance of Infectious Herpes Simplex Virus Type 1 from Sensory Ganglia and Spinal Cords J. Virol., October 1, 2008; 82(19): 9678 - 9688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Bettahi, A. B. Nesburn, S. Yoon, X. Zhang, A. Mohebbi, V. Sue, A. Vanderberg, S. L. Wechsler, and L. BenMohamed Protective Immunity against Ocular Herpes Infection and Disease Induced by Highly Immunogenic Self-Adjuvanting Glycoprotein D Lipopeptide Vaccines Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4643 - 4653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Nesburn, I. Bettahi, G. Dasgupta, A. A. Chentoufi, X. Zhang, S. You, N. Morishige, A. J. Wahlert, D. J. Brown, J. V. Jester, et al. Functional Foxp3+ CD4+ CD25(Bright+) "Natural" Regulatory T Cells Are Abundant in Rabbit Conjunctiva and Suppress Virus-Specific CD4+ and CD8+ Effector T Cells during Ocular Herpes Infection J. Virol., July 15, 2007; 81(14): 7647 - 7661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Dobbs, J. E. Strasser, C.-F. Chu, C. Chalk, and G. N. Milligan Clearance of Herpes Simplex Virus Type 2 by CD8+ T Cells Requires Gamma Interferon and either Perforin- or Fas-Mediated Cytolytic Mechanisms J. Virol., December 1, 2005; 79(23): 14546 - 14554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Gillgrass, S. A. Fernandez, K. L. Rosenthal, and C. Kaushic Estradiol Regulates Susceptibility following Primary Exposure to Genital Herpes Simplex Virus Type 2, while Progesterone Induces Inflammation J. Virol., March 1, 2005; 79(5): 3107 - 3116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Gillgrass, V. A. Tang, K. M. Towarnicki, K. L. Rosenthal, and C. Kaushic Protection against Genital Herpes Infection in Mice Immunized under Different Hormonal Conditions Correlates with Induction of Vagina-Associated Lymphoid Tissue J. Virol., March 1, 2005; 79(5): 3117 - 3126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Ashkar, S. Bauer, W. J. Mitchell, J. Vieira, and K. L. Rosenthal Local Delivery of CpG Oligodeoxynucleotides Induces Rapid Changes in the Genital Mucosa and Inhibits Replication, but Not Entry, of Herpes Simplex Virus Type 2 J. Virol., August 15, 2003; 77(16): 8948 - 8956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kaushic, A. A. Ashkar, L. A. Reid, and K. L. Rosenthal Progesterone Increases Susceptibility and Decreases Immune Responses to Genital Herpes Infection J. Virol., April 15, 2003; 77(8): 4558 - 4565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Koelle and L. Corey Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research Clin. Microbiol. Rev., January 1, 2003; 16(1): 96 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Eo, U. Kumaraguru, and B. T. Rouse Plasmid DNA Encoding CCR7 Ligands Compensate for Dysfunctional CD8+ T Cell Responses by Effects on Dendritic Cells J. Immunol., October 1, 2001; 167(7): 3592 - 3599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Eo, M. Gierynska, A. A. Kamar, and B. T. Rouse Prime-Boost Immunization with DNA Vaccine: Mucosal Route of Administration Changes the Rules J. Immunol., May 1, 2001; 166(9): 5473 - 5479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Harandi, B. Svennerholm, J. Holmgren, and K. Eriksson Differential roles of B cells and IFN-{{gamma}}-secreting CD4+ T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice J. Gen. Virol., April 1, 2001; 82(4): 845 - 853. [Abstract] [Full Text]
|
|
|
|
|
|
N. A. Kuklin, L. Rott, N. Feng, M. E. Conner, N. Wagner, W. Muller, and H. B. Greenberg Protective Intestinal Anti-Rotavirus B Cell Immunity Is Dependent on {{alpha}}4{{beta}}7 Integrin Expression But Does Not Require IgA Antibody Production J. Immunol., February 1, 2001; 166(3): 1894 - 1902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Eo, S. Lee, S. Chun, and B. T. Rouse Modulation of Immunity against Herpes Simplex Virus Infection via Mucosal Genetic Transfer of Plasmid DNA Encoding Chemokines J. Virol., January 15, 2001; 75(2): 569 - 578. [Abstract] [Full Text]
|
|
|
|
|
|
J.-I. Sin, J. J. Kim, C. Pachuk, C. Satishchandran, and D. B. Weiner DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo J. Virol., December 1, 2000; 74(23): 11173 - 11180. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-I. Sin, V. Ayyavoo, J. Boyer, J. Kim, R. B. Ciccarelli, and D. B. Weiner Protective immune correlates can segregate by vaccine type in a murine herpes model system Int. Immunol., November 1, 1999; 11(11): 1763 - 1773. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
